Prothena Corp Public (PRTA) Income towards Parent Company (2012 - 2026)

Prothena Corp Public's (PRTA) quarterly Income towards Parent Company came in at $32.7 million in Q1 2026, up 154.36% year-on-year from $12.9 million in Q1 2025, and up 251.89% quarter-over-quarter from -$21.5 million in Q4 2025.

Prothena Corp Public (PRTA) Income towards Parent Company (2012 - 2026) Analysis & Trends

Prothena Corp Public's Income towards Parent Company history runs 15 years deep, the most recent figure standing at $32.7 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company rose 154.36% year-over-year to $32.7 million in Q1 2026; TTM through Mar 2026 was -$151.1 million, a 36.91% decrease from a year earlier, with the FY2025 full-year figure at -$244.1 million, down 99.57% from the prior year.
  • Income towards Parent Company improved to $32.7 million in Q1 2026 per PRTA's latest filing, from -$21.5 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $66.8 million in Q2 2024 and bottomed at -$125.8 million in Q2 2025.
  • The 5-year median for Income towards Parent Company is -$45.7 million (2022), against an average of -$35.2 million.
  • Across the five-year window, Income towards Parent Company slumped 1162.78% in 2023 and jumped 222.43% in 2024, its largest moves.
  • Year by year, Income towards Parent Company stood at $6.3 million in 2022, then slumped by 1162.78% to -$67.5 million in 2023, then rose by 14.07% to -$58.0 million in 2024, then soared by 62.85% to -$21.5 million in 2025, then jumped by 251.89% to $32.7 million in 2026.
  • Per Business Quant, the three latest PRTA Income towards Parent Company figures stand at $32.7 million (Q1 2026), -$21.5 million (Q4 2025), and -$36.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Prothena Corp Public 471.02 Mn 141.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 32.72 Mn
Dec 31, 2025 -21.54 Mn
Sep 30, 2025 -36.51 Mn
Jun 30, 2025 -125.77 Mn
Mar 31, 2025 -60.20 Mn
Dec 31, 2024 -57.98 Mn
Sep 30, 2024 -59.04 Mn
Jun 30, 2024 66.85 Mn
Mar 31, 2024 -72.24 Mn
Dec 31, 2023 -67.48 Mn
Sep 30, 2023 21.92 Mn
Jun 30, 2023 -54.60 Mn
Mar 31, 2023 -46.88 Mn
Dec 31, 2022 6.35 Mn
Sep 30, 2022 -45.72 Mn
Jun 30, 2022 -41.27 Mn
Mar 31, 2022 -36.29 Mn
Dec 31, 2021 -33.14 Mn
Sep 30, 2021 109.25 Mn
Jun 30, 2021 27.60 Mn